Modulation of Cardiac Ventricular Excitability by GLP-1 (Glucagon-Like Peptide-1)

BACKGROUND: Glucagon-like peptide-1 receptor (GLP-1R) agonists improve cardiovascular outcomes in patients with type 2 diabetes mellitus. However, systemic actions of these agents cause sympathetic activation, which is generally considered to be detrimental in cardiovascular disease. Despite signifi...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Circ Arrhythm Electrophysiol
Main Authors: Ang, Richard, Mastitskaya, Svetlana, Hosford, Patrick S., Basalay, Marina, Specterman, Mark, Aziz, Qadeer, Li, Yiwen, Orini, Michele, Taggart, Peter, Lambiase, Pier D., Gourine, Andrey, Tinker, Andrew, Gourine, Alexander V.
Formato: Artigo
Idioma:Inglês
Publicado em: Lippincott Williams & Wilkins 2018
Assuntos:
Original Articles
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6553567/
https://ncbi.nlm.nih.gov/pubmed/30354404
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1161/CIRCEP.118.006740
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados